In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
|Videos|October 28, 2016
Jonathan Schoenfeld Answers: Which Patients Benefit Most from Immunotherapy and Radiation
Author(s)Jonathan Schoenfeld, MD, MPhil, MPH
Jonathan Schoenfeld discusses the patient profile that would benefit best from a combination of radiation and immunotherapy.
Advertisement
Jonathan Schoenfeld, MD, MPhil, MPH, of Dana-Farber Cancer Institute, discusses which patients would benefit most from a combination of immunotherapy and radiation treatment.
Right now, patients with local or locally-advanced disease, or with suppressed immune systems are not thought to be the best candidates for immunotherapy. However, Schoenfeld believes that will change with the advances being made.
Advertisement
Related to this article
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.
At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.
At ASTRO 2026, Dr. Erica Braschi Jordan details toxicity tracking, physical therapy referral, and quality of life in proton regional nodal irradiation.
At ASTRO 2026, Dr. Mishaal Munir details how nurse-led triage workflows and prompt symptom escalations improve care for breast cancer brain metastases.
ASTRO 2026 presenter Kayla Kafka-Peterson details an Adapt-Adopt-Build model to bridge global brachytherapy nursing gaps and standardize perioperative care.
At ASTRO 2026, Dr. Nitin Ohri details additive versus synergistic toxicities when combining radiation with novel systemic therapies in clinical trials.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Maintenance Tucatinib for Advanced HER2+ Breast Cancer
2
National PA Week: Mark Honor on the Growth of APPs in Oncology Care
3
IMS 2026: Beth Faiman Talks New Definition of Myeloma Cure and More
4
Daily Symptom Shifts Linked to Quality of Life in Metastatic Breast Cancer
5